Related Experiment Video
Updated: Jul 19, 2026
06:14
Translational Rabbit Model of Chronic Cardiac Pacing
Published on: January 6, 2023
Pacemaker longevity: are we getting what we are promised?
Janek Senaratne1, Marleen E Irwin, Manohara P J Senaratne
1Division of Cardiology, Grey Nuns Hospital, University of Alberta, Edmonton, Alberta, Canada.
Pacing and Clinical Electrophysiology : PACE
|October 14, 2006
Summary
Pacemaker longevity is often overestimated by manufacturers. Actual device lifespan is shorter than projected, highlighting the need for careful programming to extend battery life and avoid premature replacement.
Area of Science:
- Biomedical Engineering
- Medical Device Technology
- Cardiology
Background:
- Pacemaker longevity projections by manufacturers often rely on overestimated output parameters.
- Clinical programming parameters differ significantly from those used in manufacturer longevity estimates.
- Inaccurate longevity projections can lead to unexpected device failures and patient inconvenience.
Purpose of the Study:
- To compare actual pacemaker longevity with calculated longevity based on individual usage and programmed parameters.
- To evaluate the accuracy of manufacturer-provided pacemaker longevity projections.
- To identify factors influencing pacemaker battery depletion and actual device lifespan.
Main Methods:
- Analysis of 124 pacemakers replaced between 1998-2003.
- Obtaining pacemaker cell characteristics from manufacturers and programmed parameters from patient visits.
- Calculating current drain per interval and average lifetime current drain for each device.
- Comparing calculated longevity with observed actual longevity.
Main Results:
- Pacemakers lasted an average of 491 days less than calculated.
- Significant differences in longevity were observed between different pacemaker manufacturers.
- While not statistically significant, differences were noted between dual- and single-chamber devices.
Conclusions:
- A significant discrepancy exists between calculated and actual pacemaker longevity, with batteries depleting earlier than expected.
- Ancillary functions and pre-implantation drain may contribute to reduced pacemaker lifespan.
- Optimized programming of pacemaker outputs, modes, and functions can potentially extend device longevity and reduce the need for replacement surgery.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:30Pulse rhythm
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
01:27Specialized Characteristics of Cardiac Muscles
The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
01:19Conduction System of the Heart
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...